Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02540512Phase 1Withdrawn
Phase 1, randomised, single-blind trial (3 arms), sponsored by Loma Linda University. Primary endpoint: Pain Intensity Measure at 48 hours. Planned start Jul 2017; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02540512.